Cargando…

Aligning quality of life and guidelines for off-label psychotropic drugs in adults with intellectual disabilities and challenging behaviour

INTRODUCTION: Adults with intellectual disabilities have an increased vulnerability to mental health problems and challenging behaviour. In addition to psychotherapeutic or psychoeducational methods, off-label pharmacotherapy, is a commonly used treatment modality. OBJECTIVE: The aim of this study w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laermans, P., Morisse, F., Lombardi, M., Gérard, S., Vandevelde, S., de Kuijper, G., Audenaert, K., Claes, C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197992/ https://www.ncbi.nlm.nih.gov/pubmed/37213586 http://dx.doi.org/10.1080/20473869.2023.2195721

Ejemplares similares

Quality of Life in Persons with Intellectual Disabilities and Mental Health Problems: An Explorative Study
por: Morisse, Filip, et al.
Publicado: (2013)

Deprescribing psychotropic medicines for behaviours that challenge in people with intellectual disabilities: a systematic review
por: Adams, Danielle, et al.
Publicado: (2023)

An Exploratory Study among Intellectual Disability Physicians on the Care and Coercion Act and the Use of Psychotropic Drugs for Challenging Behaviour
por: bij de Weg, Janouk C., et al.
Publicado: (2021)

Audit of Adherence to Prescribing Guidelines of Psychotropic Drugs for People With Intellectual Disability and Behaviours That Challenge -Specialist Support Team -SST-Merseycare NHS Foundation Trust
por: Hasan, Syeda, et al.
Publicado: (2022)

Withdrawing Antipsychotics for Challenging Behaviours in Adults with Intellectual Disabilities: Experiences and Views of Prescribers
por: de Kuijper, Gerda, et al.
Publicado: (2022)

Pharmacogenomics: an opportunity for personalised psychotropic prescribing in adults with intellectual disabilities
por: Perera, Bhathika, et al.
Publicado: (2022)

Withdrawing Antipsychotics for Challenging Behaviours in Adults with Intellectual Disabilities: Experiences and Views of Experts by Experience
por: de Kuijper, Gerda, et al.
Publicado: (2022)

Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study
por: Sheehan, Rory, et al.
Publicado: (2015)

Audit on use of PRN (pro re nata) psychotropic medication for behavioural disturbance in individuals with intellectual disability in the community
por: Dhandapani, Asha, et al.
Publicado: (2021)

Improving knowledge of psychotropic prescribing in people with Intellectual Disability in primary care
por: Shankar, Rohit, et al.
Publicado: (2018)

Psychotropic drugs intake in people aging with intellectual disability: Prevalence and predictors
por: García‐Domínguez, Laura, et al.
Publicado: (2022)

Management of psychotropic medications in adults with intellectual disability: a scoping review
por: Costello, Ashley, et al.
Publicado: (2022)

Non‐pharmacological interventions for challenging behaviours of adults with intellectual disabilities: A meta‐analysis
por: Bruinsma, E., et al.
Publicado: (2020)

De-Prescribing of Psychotropic Medications in the Adult Population with Intellectual Disabilities: A Commentary
por: Flood, Bernadette
Publicado: (2018)

Management of psychotropic medications in adults with intellectual disability: a scoping review protocol
por: Costello, Ashley, et al.
Publicado: (2022)

Exploring the association of staff characteristics with staff perceptions of quality of life of individuals with intellectual disabilities and challenging behaviours
por: Bruinsma, Eke, et al.
Publicado: (2022)

Appropriateness of psychotropic medication use in a cohort of adolescents with intellectual disability in Queensland, Australia
por: Song, Menghuan, et al.
Publicado: (2020)

Support staff liaising effectively with professionals for the rational use of psychotropics for behaviours that challenge in adults with intellectual disabilities: Findings from a co-design event
por: Limbu, Bharati, et al.
Publicado: (2022)

Challenging behaviours: Views and preferences of people with intellectual disabilities
por: Wolkorte, Ria, et al.
Publicado: (2019)

Changes over a decade in psychotropic prescribing for people with intellectual disabilities: prospective cohort study
por: Henderson, Angela, et al.
Publicado: (2020)

Psychotropic prescribing practices in adults with intellectual disability and autism spectrum disorder in Richmond Neurodevelpmental Services
por: Dissanayake, Anushka, et al.
Publicado: (2021)

Off-label Psychotropics Use: Isn’t it Now an Inevitable and a “Norm” in Psychiatry?
por: Khanra, Sourav, et al.
Publicado: (2018)

Difficulties in Addressing Diagnostic, Treatment and Support Needs in Individuals with Intellectual Disability and Persistent Challenging Behaviours: A Descriptive File Study of Referrals to an Expertise Centre
por: de Kuijper, Gerda, et al.
Publicado: (2023)

Perampanel and Challenging Behaviour in Intellectual Disability and Epilepsy: A Management Dilemma
por: Dolton, Emily, et al.
Publicado: (2014)

Experiences of psychotropic medication use and decision-making for adults with intellectual disability: a multistakeholder qualitative study in the UK
por: Sheehan, Rory, et al.
Publicado: (2019)

A structured medication review tool to promote psychotropic medication optimisation for adults with intellectual disability: feasibility study
por: Sheehan, Rory, et al.
Publicado: (2019)

Clinical Practice Guidelines for Assessment and Management of intellectual disability
por: Kishore, M. Thomas, et al.
Publicado: (2019)

Persons with Intellectual Disability: Sexual Behaviour, Knowledge and Assertiveness
por: Brkić-Jovanović, Nina, et al.
Publicado: (2021)

COVID-19 pandemic impact on psychotropic prescribing for adults with intellectual disability: an observational study in English specialist community services
por: Naqvi, Danial, et al.
Publicado: (2021)

Influence of the organizational environment on challenging behaviour in people with intellectual disabilities: Professionals’ views
por: Olivier‐Pijpers, Vanessa C., et al.
Publicado: (2018)

Challenging behaviour in students with intellectual disabilities: the role of individual and classmates' communication skills
por: Hofmann, V., et al.
Publicado: (2022)

Overdose and off-label psychotropic prescribing in patients with borderline personality disorder: A retrospective series
por: Ning, Anna Y, et al.
Publicado: (2023)

Psychotropic medication for challenging behavior in people with learning disabilities in Qatar
por: Eltorki, Y., et al.
Publicado: (2021)

Psychotropic medication and psychotherapeutic treatment of adults with intellectual disabilities (PROMPT-ID): a cross-sectional, epidemiological study in Saxony, Germany
por: Koch, Andrea, et al.
Publicado: (2018)

Recommending Physical Activity for People with Intellectual Disabilities: The Relevance of Public Health Guidelines, Physical Activity Behaviour and Type of Contact
por: Kreinbucher-Bekerle, Christoph, et al.
Publicado: (2023)

Attributional styles of support staff working with people with intellectual disabilities exhibiting challenging behaviour
por: van den Bogaard, Kim J. H. M., et al.
Publicado: (2019)

Clinical guidelines contribute to the health inequities experienced by individuals with intellectual disabilities
por: Mizen, Lindsay AM, et al.
Publicado: (2012)

Correlates of Sedentary Behaviour in Adults with Intellectual Disabilities—A Systematic Review
por: Oppewal, Alyt, et al.
Publicado: (2018)

Pharmacological interventions for challenging behaviour in children with intellectual disabilities: a systematic review and meta-analysis
por: McQuire, Cheryl, et al.
Publicado: (2015)

UK psychiatrists’ experience of withdrawal of antipsychotics prescribed for challenging behaviours in adults with intellectual disabilities and/or autism
por: Deb, Shoumitro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_efumbcslkd2u81vsch0huha0ij